CD44 and phosphorylated ERK1/2 coexpression predicts distant metastasis in colorectal cancer based on a study of 1137 Saudi patients

Sandeep Kumar Parvathareddy, Abdul K. Siraj, Padmanaban Annaiyappanaidu, Fouad Al-Dayel, Khawla S. Al-Kuraya · 2025

Read CD44 and phosphorylated ERK1/2 coexpression predicts distant metastasis in colorectal cancer based on a study of 1137 Saudi patients by Sandeep Kumar Parvathareddy, Abdul K. Siraj, Padmanaban Annaiyappanaidu, Fouad Al-Dayel, Khawla S. Al-Kuraya (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12715184.txt.

Description

Sandeep Kumar Parvathareddy and co-authors test in 2025 whether two protein markers together flag colorectal cancers likely to spread. The surface protein CD44 aids tumor growth, and an activated growth signal protein drives cancer pathways. They stained tissue from 1,137 Saudi patients and linked marker patterns to disease traits and outcomes with standard statistical models.

CD44 was high in about forty-eight percent of tumors and tied to node spread and higher stage. Alone it did not predict survival. Tumors positive for both markers, about a quarter of cases, spread distantly more often. The pair independently predicted distant spread, marking a high-risk group.

Catalog record

CREATORSandeep Kumar Parvathareddy, Abdul K. Siraj, Padmanaban Annaiyappanaidu, Fouad Al-Dayel, Khawla S. Al-Kuraya
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12715184

Browse the full library · About the Tower of Babel